PDGFRB and gastric adenocarcinoma: For example, PDGFRB overexpression was significantly associated with poor survival in stomach adenocarcinoma (STAD) (log rank test p=0.016), brain lower grade glioma (LGG) (log rank test p=0.029), kidney renal papillary cell carcinoma (KIRP) (log rank test p=0.00004) and bladder urothelial carcinoma (BLCA) (log rank test p=0.0076).